Literature DB >> 4566436

Binding of bacteriophage P22 tail parts to cells.

V Israel, H Rosen, M Levine.   

Abstract

Purified base-plate parts of bacteriophage P22 can bind to the host cell, Salmonella typhimurium. Although the reaction is reversible, a stable equilibrium is not formed between bound and unbound base-plate parts. This is because the binding sites on the cell, presumably the O antigens, are destroyed. The destruction of binding sites does not kill the cells, and, in fact, the binding sites are soon regenerated. The site-destroying activity reacts with P22 heads to make active phage and with antiserum made against purified phage. Therefore site-destroying activity is a characteristic of the base-plate parts and not some contaminant of the preparation.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4566436      PMCID: PMC356596     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  6 in total

1.  TWO SEQUENTIAL REPRESSIONS OF DNA SYNTHESIS IN THE ESTABLISHMENT OF LYSOGENY BY PHAGE P22 AND ITS MUTANTS.

Authors:  H O SMITH; M LEVINE
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  Mutations in the temperate phage P22 and lysogeny in Salmonella.

Authors:  M LEVINE
Journal:  Virology       Date:  1957-02       Impact factor: 3.616

3.  Lysogenization and superinfection immunity in Salmonella.

Authors:  N D ZINDER
Journal:  Virology       Date:  1958-04       Impact factor: 3.616

4.  in vitro MORPHOGENESIS OF PHAGE P22 FROM HEADS AND BASE-PLATE PARTS.

Authors:  J V Israel; T F Anderson; M Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1967-02       Impact factor: 11.205

5.  Classification of aminotransferase (C gene) mutants in the histidine operon.

Authors:  H J Whitfield; R G Martin; B N Ames
Journal:  J Mol Biol       Date:  1966-11-14       Impact factor: 5.469

Review 6.  Molecular aspects of lipopolysaccharides.

Authors:  A Wright; S Kanegasaki
Journal:  Physiol Rev       Date:  1971-10       Impact factor: 37.312

  6 in total
  18 in total

Review 1.  Molecular genetics of bacteriophage P22.

Authors:  M M Susskind; D Botstein
Journal:  Microbiol Rev       Date:  1978-06

2.  Bacteriophage P22 virion protein which performs an essential early function. I. Analysis of 16-ts mutants.

Authors:  B Hoffman; M Levine
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

3.  Structure and functions of the bacteriophage P22 tail protein.

Authors:  P B Berget; A R Poteete
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

4.  Visualizing the structural changes of bacteriophage Epsilon15 and its Salmonella host during infection.

Authors:  Juan T Chang; Michael F Schmid; Cameron Haase-Pettingell; Peter R Weigele; Jonathan A King; Wah Chiu
Journal:  J Mol Biol       Date:  2010-08-13       Impact factor: 5.469

5.  E proteins of bacteriophage P22. I. Identification and ejection from wild-type and defective particles.

Authors:  V Israel
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

6.  Bacteriophage P22-mediated specialized transduction in Salmonella typhimurium: high frequency of aberrant prophage excision.

Authors:  D Y Kwoh; J Kemper
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

7.  Bacteriophage P22-mediated specialized transduction in Salmonella typhimurium: identification of different types of specialized transducing particles.

Authors:  D Y Kwoh; J Kemper
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

8.  Sonic fragility of the head-tail bond of bacteriophage P22.

Authors:  M Ruddel; V Israel
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

9.  Role of the bacteriophage P22 tail in the early stages of infection.

Authors:  V Israel
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

10.  Choline-containing bacteriophage receptors in Streptococcus pneumoniae.

Authors:  R Lopez; E Garcia; P Garcia; C Ronda; A Tomasz
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.